Aceruloplasminemia

Journal of the Neurological Sciences

Volumn 207, Issue 1-2, 2003, Pages 108-109

  Harris, Z Leah ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; FERROUS ION; GLYCOPROTEIN; IRON BINDING PROTEIN;

ACERULOPLASMINEMIA; AUTOSOMAL RECESSIVE DISORDER; BLEPHAROSPASM; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; COPPER DEFICIENCY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; HOMEOSTASIS; HUMAN; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; IRON THERAPY; IRON TRANSPORT; LIPID PEROXIDATION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION;

ANIMALS; CERULOPLASMIN; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS;

EID: 12244281826     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00434-3     Document Type: Conference Paper

References (24)

1. Miyajima H., Nishimura Y., Mizoguchi K.et al. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 37:1987;761-767.
2. Harris Z.L., Takahashi Y., Miyajima H.et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2539-2543.
3. Yoshida K., Furihata K., Takeda S.et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9:1995;267-272.
4. Daimon M., Kato T., Kawanami T., Tominaga M.et al. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem. Biophys. Res. Commun. 217:1995;89-95.
5. Harris Z.L., Migas M.D., Hughes A.E.et al. Familial dementia due to a frameshift mutation in the ceruloplasmin gene. Q. J. Med. 89:1996;355-359.
6. Okamoto N., Wada S., Oga T., Kawabata Y.et al. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum. Genet. 97:1996;755-778.
7. Hellman N.E., Kono S., Miyajima H., Gitlin J.D. Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277:2002;1375-1380.
8. Osaki S., Johnson D., Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241:1966;2746-2757.
9. Lee G.R., Nacht S., Lukens J.N., Cartwright G.E. Iron metabolism in copper-deficient swine. J. Clin. Invest. 47:1968;2058-2069.
10. Roeser H.P., Lee G.R., Nacht S., Cartwright G.E. The role of ceruloplasmin in iron metabolism. J. Clin. Invest. 49:1970;2408-2417.
11. Osaki S., Johnson D.A., Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase. J. Biol. Chem. 246:1971;3018-3023.
12. Askwith C., Eide D., VanHo A., Bernard P.S.et al. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell. 76:1994;403-410.
13. Stearman R., Yuan D., Yamaguchi-Iwa Y.et al. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science. 271:1996;1552-1557.
14. Klomp L.W.J., Gitlin J.D. Expression of the ceruloplasmin gene in the human retina and brain: implications for the pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5:1996;1989-1996.
15. Patel B.N., David S. A novel glycophosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272:1997;20185-20190.
16. Salzer J.L., Lovejoy L., Linder M.C., Rosen C. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J. Neurosci. Res. 54:1998;147-157.
17. Fortna R.R., Watson H.A., Nyquist S.E. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed in Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod. 61:1999;1042-1049.
18. Harris Z.L., Durley A.P., Man T.K., Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10812-10817.
19. Meyer L.A., Durley A.P., Prohaska J.R., Harris Z.L. Copper transport and metabolism are normal in aceruloplasminemic mice. J. Biol. Chem. 276:2001;36857-36861.
20. Patel B.N., Dunn R.J., Jeong S.Y.et al. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22:2002;6578-6586.
21. Miyajima H., Takahashi Y., Serizawa M.et al. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic. Biol. Med. 20:1996;757-760.
22. Yoshida K., Kaneko K., Miyajima H.et al. Increased lipid peroxidation in the brains of aceruloplasminemic patients. J. Neurol. Sci. 175:2000;91-95.
23. Kohno S., Miyajima H., Takahashi Y.et al. Defective electron transfer in complexes I and IV in patients with aceruloplasminemia. J. Neurol. Sci. 182:2000;57-60.
24. Kaneko K., Nakamura A., Yoshida K.et al. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic. Res. 36:2002;303-306.